semaglutide approved New Weight Loss Medication Wegovy™ by the FDA Is Compounded Semaglutide Safe?

If you are thinking about treatment eligibility, take the free assessment quiz to see whether a personalized program is a fit for you

While tirzepatide is a GLP-1 agonist, it also works on GIP, which may make it more effective, but studies are limited at this time

You may be a candidate if you: Meet medical eligibility for obesity/overweight or type 2 diabetes Are ready to pair medication with nutrition, movement, and sleep changes Want ongoing guidance and accountability from our clinical team We do not prescribe if there are contraindications or if it isnt clinically appropriate

Alternating medications could theoretically affect hair loss risk if the cycling produces inconsistent weight loss patterns with periods of rapid loss followed by stabilization followed by rapid loss again